165 related articles for article (PubMed ID: 11592096)
1. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2001 Sep; 195(2):179-85. PubMed ID: 11592096
[TBL] [Abstract][Full Text] [Related]
2. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry.
El-Sherif AM; Seth R; Tighe PJ; Jenkins D
J Pathol; 2000 Dec; 192(4):494-501. PubMed ID: 11113867
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix.
Sharma A; Rajappa M; Saxena A; Sharma M
Int J Gynecol Cancer; 2007; 17(4):879-85. PubMed ID: 17343606
[TBL] [Abstract][Full Text] [Related]
6. Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.
Wang L; Li H; Liang F; Hong Y; Jiang S; Xiao L
Med Oncol; 2014 Sep; 31(9):143. PubMed ID: 25106529
[TBL] [Abstract][Full Text] [Related]
7. [Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report].
Pardo-Govea T; Callejas D; Núñez-Troconis J; Araujo M; Costa L; Pons H; Delgado M; Monsalve F
Invest Clin; 2005 Mar; 46(1):5-13. PubMed ID: 15782532
[TBL] [Abstract][Full Text] [Related]
8. Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.
Scott ME; Ma Y; Kuzmich L; Moscicki AB
Int J Cancer; 2009 Mar; 124(6):1379-83. PubMed ID: 19089920
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
Yang W; Song Y; Lu YL; Sun JZ; Wang HW
Immunology; 2013 Aug; 139(4):513-22. PubMed ID: 23521696
[TBL] [Abstract][Full Text] [Related]
10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
11. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
Bais AG; Beckmann I; Lindemans J; Ewing PC; Meijer CJ; Snijders PJ; Helmerhorst TJ
J Clin Pathol; 2005 Oct; 58(10):1096-100. PubMed ID: 16189158
[TBL] [Abstract][Full Text] [Related]
12. Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.
Tirone NR; Peghini BC; Barcelos AC; Murta EF; Michelin MA
Cancer Immunol Immunother; 2009 Dec; 58(12):2003-10. PubMed ID: 19381629
[TBL] [Abstract][Full Text] [Related]
13. Evolving immunosuppressive microenvironment during human cervical carcinogenesis.
Kobayashi A; Weinberg V; Darragh T; Smith-McCune K
Mucosal Immunol; 2008 Sep; 1(5):412-20. PubMed ID: 19079205
[TBL] [Abstract][Full Text] [Related]
14. IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.
DeCarlo CA; Severini A; Edler L; Escott NG; Lambert PF; Ulanova M; Zehbe I
Lab Invest; 2010 Oct; 90(10):1482-91. PubMed ID: 20479716
[TBL] [Abstract][Full Text] [Related]
15. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
Front Immunol; 2020; 11():612547. PubMed ID: 33552075
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
Passmore JA; Milner M; Denny L; Sampson C; Marais DJ; Allan B; Gumbi PP; Hitzeroth II; Rybicki EP; Williamson AL
Immunology; 2006 Dec; 119(4):507-14. PubMed ID: 17026720
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
18. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection.
Sasagawa T; Shimakage M; Nakamura M; Sakaike J; Ishikawa H; Inoue M
Hum Pathol; 2000 Mar; 31(3):318-26. PubMed ID: 10746674
[TBL] [Abstract][Full Text] [Related]
20. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
Kobayashi A; Greenblatt RM; Anastos K; Minkoff H; Massad LS; Young M; Levine AM; Darragh TM; Weinberg V; Smith-McCune KK
Cancer Res; 2004 Sep; 64(18):6766-74. PubMed ID: 15374995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
